Moreover, regarding the research on the action mechanisms of cinobufagin in the inhibition of CRC, experimental data have indicated that cinobufagin evidently suppresses CRC cell viability via the STAT3 pathway inhibition, promotes apoptosis, and represses proliferation and migration of CRC cells. The gene discussed is STAT3; the disease is colorectal carcinoma.